Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation.
Trimetazidine, a piperazine derivative used as an anti-anginal agent, improves myocardial glucose utilization through inhibition of fatty acid metabolism. The present study was designed to investigate whether trimetazidine has the protective effects against smoking-induced left ventricular remodelin...
Saved in:
Main Authors: | Xiang Zhou, Chao Li, Weiting Xu, Jianchang Chen |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/8074a9dd820f45b69f4d854ef0ada5cd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Left ventricular remodeling patterns in children with metabolic syndrome
by: Veronica ESANU, et al.
Published: (2020) -
Factors associated with left ventricular reverse remodelling after percutaneous coronary intervention in patients with left ventricular systolic dysfunction
by: Yusuke Adachi, et al.
Published: (2021) -
Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction
by: Michał Węgiel, et al.
Published: (2021) -
Patterns of left ventricular remodeling among patients with essential and secondary hypertension
by: Radulescu,Dan, et al.
Published: (2013) -
Effects of triptolide and methotrexate nanosuspensions on left ventricular remodeling in autoimmune myocarditis rats
by: Li W, et al.
Published: (2019)